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Chronic myelogenous leukemia (CML) is caused by chromosomal 
translocations resulting in the generation of Bcr-Abl fusion oncogene in a 
hematopoietic stem cell. The robust increase in CML cells during the chronic 
phase may be controlled by Bcr-Abl tyrosine kinase inhibitors (TKIs), but the 
CML-initiating cells per se are resistant to TKIs and may persist as minimal 
residual disease. Sipa1 is a specific Rap1 GTPase-activating protein (GAP) that 
negatively regulates Rap1 signaling, which controls cell–cell and cell–matrix 
interactions, and functions as a key endogenous regulator of cell adhesion and 
migration for many cell types in tissues. In this study, the CML-inducing activity 
of primary Bcr-Abl+ hematopoietic progenitor cells (HPCs) from wild-type (Wt) 
mice in Sipa1–/– hosts was investigated. Sipa1–/– mice showed a remarkable 
resistance to CML development upon transfer of Bcr-Abl+ HPCs, which cause 
lethal CML disease in Wt mice. This resistance required both T cells and 
mesenchymal stroma cells (MSCs) in Sipa1–/– hosts. Furthermore, Sipa1 
deficient MSCs showed enhanced activation and directed migration (haptotaxis) 
to Bcr-Abl+ CML cells in tissue and preferentially produced Cxcl9, and Sipa1 
deficient memory T cells also exhibited remarkably augmented chemotactic 
activity in response to Cxcl9. The results uncovered a potent immune 
mechanism capable of eradicating Bcr-Abl+ HPCs via coordinated interplay 
between MSCs and immune T cells. Although the mechanism is latent in Wt 
mice, it is liberated by the deletion of Sipa1 leading to the complete cure of CML 

















  したがって、本論文は博士（ 医科学 ）の学位論文として価値あるものと認める。 
  なお、本学位授与申請者は、平成 30年 04月 23日実施の論文内容とそれに関連した
試問を受け、合格と認められたものである。 
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